NY FamilyHealth MSSP Enhanced
Victoria Njoku-Anokam
Executive Director
(917) 983-5669
Location
Location

FamilyHealth ACO, LLC

2006 Madison Ave
New York, NY 10035
 

ACO Participants ACO Participant in Joint Venture
Brightpoint Health N
HUDSON RIVER HEALTHCARE INC N
Open Door Family Medical Center Inc N
The Institute for Family Health N

First Name Last Name Member's Voting Power (Expressed as a percentage or number) Membership Type Practice Legal Business Name
Neil Calman 1 ACO Participant Representative The Institute for Family Health
Carole Furman 1 Medicare Beneficiary Representative N/A
Maxine Golub 1 ACO Participant Representative The Institute for Family Health
Robert Schiller 1 ACO Participant Representative The Institute for Family Health
Lindsay Farrell 1 ACO Participant Representative Open Door Family Medical Center Inc
Anne Nolon 1 ACO Participant Representative Hudson River Healthcare Inc
James Sinkoff 1 ACO Participant Representative Hudson River Healthcare Inc
Mat Kendall 1 Other Aledade
Victoria Njoku-Anokam 0 Other Aledade
  • ACO Executive: Victoria Njoku-Anokam
  • Medical Director:  Dr. Robert Schiller
  • Chief Financial Officer: Maria Mazzotta
  • Chief Information Officer: Elizabeth Lever
  • Quality Assurance / Improvement Officer: Dr. Sophia McIntyre
  • Compliance Officer: Julie Peskoe
  • Dr. Neil Calman, Board of Managers
  • James Sinkoff, Finance Committee
  • Lindsay Farrell, Analytics & Quality Improvement
  • Federally qualified health centers (FQHCs)

Third Agreement Period

  • Performance Year 2020, $ 7,366,838

Second Agreement Period

  • Performance Year 2019, $4,610,857
  • Performance Year 2018, $1,607,869
  • Performance Year 2017, $1,619,619

First Agreement Period

  • Performance Year 2016, $0
  • Performance Year 2015, $0
  • Performance Year 2014, $0

Third Agreement Period

  • Performance Year 2020
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care: 30%
    • Proportion of distribution to ACO participants: 60% 

Second Agreement Period

  • Performance Year 2019
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care: 30%
    • Proportion of distribution to ACO participants: 60% 
  • Performance Year 2018
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care: 30%
    • Proportion of distribution to ACO participants: 60% 
  • Performance Year 2017
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care: 30%
    • Proportion of distribution to ACO participants: 60% 

 

2020 Quality Performance Results:
ACO#
Measure Name
Rate
ACO Mean
ACO-8
Risk Standardized, All Condition Readmission
15.01
15.07
ACO-38
Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions
59.42
49.50
ACO-43
Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))
1.13
0.95
ACO-13
Falls: Screening for Future Fall Risk
67.81
84.97
ACO-14
Preventive Care and Screening: Influenza Immunization
73.45
76.03
ACO-17
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
89.61
81.67
ACO-18
Preventive Care and Screening: Screening for Depression and Follow-up Plan
61.28
71.46
ACO-19
Colorectal Cancer Screening
66.98
72.59
ACO-20
Breast Cancer Screening
61.18
74.05
ACO-42
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
83.20
83.37
ACO-40
Depression Remission at Twelve Months
16.28
13.99
ACO-27
Diabetes Mellitus: Hemoglobin A1c Poor Control
24.34
14.70
ACO-28
Hypertension (HTN): Controlling High Blood Pressure
69.42
72.87


For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov.

 

Payment Rule Waivers

Waiver for Payment for Telehealth Services:

  • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.
Fraud and Abuse Waivers